Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Coordinating Center (CCC) & Data Coordinating Center (DCC)
Forecasted
The NIH plans to continue funding centers that coordinate clinical trials and data management for NeuroNEXT, advancing research and therapies for neurological disorders in adults and children.
Funder: National Institutes of Health
Due Dates (Anticipated): November 2027 (estimated application due date)
Funding Amounts: Expected 2 awards; funding details not yet announced; cooperative agreement mechanism.
Summary: Supports infrastructure for the NeuroNEXT network to accelerate clinical trials and biomarker studies in neurological disorders via Clinical and Data Coordinating Centers.
Key Information: This is a forecasted opportunity—applications are not being solicited yet; details may change.
Description
The National Institute of Neurological Disorders and Stroke (NINDS) at the NIH is preparing to continue support for the infrastructure of the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT). NeuroNEXT is designed to facilitate clinical trials and biomarker validation studies for a wide range of neurological disorders affecting both adult and pediatric populations. The program will invite applications to serve as the Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC), which are responsible for providing the operational, regulatory, and data management infrastructure necessary to carry out multi-site clinical research. The primary goal is to accelerate the development and validation of neurotherapeutics by supporting high-quality, collaborative, and innovative research.
